Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-27

FDA Approved: GANCICLOVIR — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Hikma's generic GANCICLOVIR SODIUM, confirming regulatory approval of this ganciclovir product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GANCICLOVIR (GANCICLOVIR SODIUM)

Snippet

SUPPL AP for GANCICLOVIR (GANCICLOVIR SODIUM)